Management of methicillin-resistant Staphylococcus aureus in The Netherlands

    loading  Checking for direct PDF access through Ovid

Abstract

The Netherlands is one of the countries that is able to keep the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at a low level. This is the result of a stringent national management policy based on: (1) strict isolation of colonized and infected patients, (2) active search for carriers by screening and treatment of carriership, (3) isolation for a few days of patients transferred to Dutch hospitals from foreign hospitals to allow screening for MRSA. The success of the approach is based on the timely implementation of a national control programme, on the national acceptance of and compliance with the guidelines, and on the traditional Dutch parsimonious use of antimicrobial agents.

Related Topics

    loading  Loading Related Articles